January 14, 2022 Consequent to the rapid increase of the hospitals where EchoLaser SoracteLite is used to treat BPH, Elesta has initiated a national project for the elaboration of a Delphi Consensus (which will be submitted for publication), aiming at standardizing...
November 1, 2021 Effective from July 1, 2022, the specific CPT code will allow EchoLaser SoracteLite treatment to spread quickly, with benefits for hospitals, payers and most of all patients. Click here to get more details.
September 6-8, 2021, Bari – Italy The 20th edition of the Italian Endourology Association will be held on September 6-8 at The Nicolaus Hotel of Bari, during the event SoracteLite procedure for the treatment of benign prostatic hyperplasia will be presented by...
October 17, 2020 Elesta is proud to announce the first presentation of MRI guided SoracteLite focal laser ablation for prostate cancer. The pre-recorded video will be presented on Saturday 17 October at 11.00 during ICEP2020 web course. Click here to access to access...
The article reports the experience of the Urology Unit of Bari University, showing good results at 6 months in efficacy, safety and ejaculation preservation. Moreover, all patients but one discontinued medical therapy. Click here to read the abstract.
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy. AcceptRead the policy
